{"id":"W3112014372","doi":"10.1016/j.annonc.2020.10.556","title":"68P Evaluation of flat dosing for nivolumab (NIVO) + ipilimumab (IPI) in first-line (1L) unresectable malignant pleural mesothelioma (MPM): CheckMate 743 (CM 743)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Dosing; Nivolumab; Internal medicine; Regimen; Population; Pharmacokinetics; Hazard ratio; Cancer; Confidence interval; Immunotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005099786,0.0004535321,0.0008482489,0.0002406977,0.0003121616,0.0007123476,0.000672571,0.0008120597,0.006605739],"category_scores_gemma":[0.0008961009,0.0002708655,0.0009579103,0.0002133275,0.0003538507,0.0004659642,0.0002353096,0.001853751,0.001099456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009747345,"about_ca_system_score_gemma":0.0009246516,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002583896,"about_ca_topic_score_gemma":0.003938605,"domain_scores_codex":[0.9997204,0.00008267935,0.00001402915,0.00007199176,0.0000442668,0.00006669251],"domain_scores_gemma":[0.999689,0.0000618735,0.0000479591,0.00002477104,0.00002121143,0.0001552391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5019953,0.02770109,0.007895016,0.0007786615,0.001428643,0.0003402335,0.00028781,0.005336256,0.07521404,0.0006699861,0.007797257,0.3705557],"study_design_scores_gemma":[0.1538261,0.7475417,0.05219217,0.0001557302,0.001456167,0.0007088622,0.0001488372,0.00715095,0.01972792,0.0004401157,0.01655974,0.00009165187],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990978,0.002181372,0.0006339098,0.0005586368,0.0001977953,0.000657787,0.001274178,0.0001462722,0.003372176],"genre_scores_gemma":[0.9950153,0.0007455233,0.0008983269,0.0004182723,0.00005572519,0.0002635428,0.0008240749,0.00003175189,0.001747436],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006605739,"threshold_uncertainty_score":0.02209842,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1805615866130504,"score_gpt":0.4066973016192427,"score_spread":0.2261357150061923,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}